MORANDI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 177
EU - Europa 116
AS - Asia 81
Continente sconosciuto - Info sul continente non disponibili 1
Totale 375
Nazione #
US - Stati Uniti d'America 175
CN - Cina 48
IE - Irlanda 31
IT - Italia 28
SG - Singapore 27
SE - Svezia 26
FI - Finlandia 11
DE - Germania 9
GB - Regno Unito 4
IN - India 3
TR - Turchia 3
AT - Austria 2
BE - Belgio 2
CA - Canada 2
FR - Francia 2
CZ - Repubblica Ceca 1
EU - Europa 1
Totale 375
Città #
Chandler 35
Dublin 31
Singapore 23
Santa Clara 22
Dearborn 16
Ann Arbor 12
Ashburn 12
Helsinki 10
New York 10
Beijing 9
Nanjing 9
Shanghai 9
Boardman 7
Parma 6
Princeton 5
Bremen 4
Nanchang 4
Izmir 3
Shenyang 3
Brussels 2
Catania 2
Jinan 2
Kunming 2
Lanzhou 2
Los Angeles 2
Pune 2
Redmond 2
San Mateo 2
Toronto 2
Venegono Inferiore 2
Vienna 2
Wilmington 2
Borås 1
Changsha 1
Chengdu 1
Des Moines 1
Erba 1
Falkenstein 1
Fuzhou 1
Guangzhou 1
Hebei 1
Houston 1
Leawood 1
London 1
Manchester 1
Milan 1
Munich 1
Redwood City 1
Scottsdale 1
Teverola 1
Tianjin 1
Totale 275
Nome #
Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 95
Survival prediction in high-grade gliomas using CT perfusion imaging 80
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III 71
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 60
Clinical validation of 13-gene DNA methylation analysis in oral brushing samples for detection of oral carcinoma: Italian multicenter study 52
SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia 23
Totale 381
Categoria #
all - tutte 1.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.764


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031 0 0 0 0 0 15 2 2 8 4 0 0
2020/202121 0 0 1 2 2 1 2 2 5 1 4 1
2021/202217 0 1 0 0 1 0 0 1 0 0 2 12
2022/2023118 11 17 8 6 10 14 0 9 37 0 2 4
2023/202456 5 0 0 1 6 16 1 10 1 4 5 7
2024/202577 3 8 11 14 18 23 0 0 0 0 0 0
Totale 381